Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Teva
Federal Trade Commission
US Army
Dow
UBS
McKesson
Boehringer Ingelheim
US Department of Justice
Colorcon

Generated: February 18, 2018

DrugPatentWatch Database Preview

Dexamethasone sodium phosphate; neomycin sulfate - Generic Drug Details

« Back to Dashboard

What are the generic sources for dexamethasone sodium phosphate; neomycin sulfate and what is the scope of dexamethasone sodium phosphate; neomycin sulfate patent protection?

Dexamethasone sodium phosphate; neomycin sulfate
is the generic ingredient in three branded drugs marketed by Merck, Bausch And Lomb, Alcon Pharms Ltd, and Pharmafair, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-nine drug master file entries for dexamethasone sodium phosphate; neomycin sulfate.
Summary for dexamethasone sodium phosphate; neomycin sulfate

US Patents and Regulatory Information for dexamethasone sodium phosphate; neomycin sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck NEODECADRON dexamethasone sodium phosphate; neomycin sulfate OINTMENT;OPHTHALMIC 050324-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmafair NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE dexamethasone sodium phosphate; neomycin sulfate SOLUTION/DROPS;OPHTHALMIC 062539-001 Jan 10, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Merck NEODECADRON dexamethasone sodium phosphate; neomycin sulfate SOLUTION/DROPS;OPHTHALMIC 050322-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bausch And Lomb NEOMYCIN SULFATE AND DEXAMETHASONE SODIUM PHOSPHATE dexamethasone sodium phosphate; neomycin sulfate SOLUTION/DROPS;OPHTHALMIC 064055-001 Oct 30, 1995 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Alcon Pharms Ltd NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE dexamethasone sodium phosphate; neomycin sulfate SOLUTION/DROPS;OPHTHALMIC 062714-001 Jul 21, 1986 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Queensland Health
Baxter
Harvard Business School
Cipla
Federal Trade Commission
Argus Health
Johnson and Johnson
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot